e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Moderate resting hypoxaemia in fibrotic interstitial lung disease
Yet H. Khor, Amelia Harrison, Julien Robinson, Nicole S.L. Goh, Ian Glaspole, Christine F. McDonald
Source:
Eur Respir J, 57 (1) 2001563; 10.1183/13993003.01563-2020
Journal Issue:
January
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Yet H. Khor, Amelia Harrison, Julien Robinson, Nicole S.L. Goh, Ian Glaspole, Christine F. McDonald. Moderate resting hypoxaemia in fibrotic interstitial lung disease. Eur Respir J, 57 (1) 2001563; 10.1183/13993003.01563-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
Nitrofurantoin-induced interstitial lung disease
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012
Mild parenchymal lung disease is still lung disease
Source: Eur Respir J, 56 (5) 2003727; 10.1183/13993003.03727-2020
Year: 2020
Mild parenchymal lung disease is still lung disease
Source: Eur Respir J, 56 (5) 2003542; 10.1183/13993003.03542-2020
Year: 2020
Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease
Source: Eur Respir J, 55 (2) 1901681; 10.1183/13993003.01681-2019
Year: 2020
Using the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Alveoscopy in diffuse interstitial lung disease
Source: Eur Respir J 2007; 30: Suppl. 51, 244s
Year: 2007
Pulmonary hypertension in interstitial lung disease
Source: Eur Respir J 2008; 31: 1357-1367
Year: 2008
Chronic obstructive pulmonary disease with preserved lung function, severe hypoxemia and emphysema
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020
Effects of hyperoxia on dyspnoea and exercise endurance in fibrotic interstitial lung disease
Source: Eur Respir J, 49 (5) 1602494; 10.1183/13993003.02494-2016
Year: 2017
Rituximab in severe, progressive interstitial lung disease
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Clubbing in patients with fibrotic interstitial lung diseases
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Rituximab in severe, treatment-refractory interstitial lung disease
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Biomarkers for pulmonary hypertension in interstitial lung disease
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Pulmonary vascular response patterns during exercise in interstitial lung disease
Source: Eur Respir J 2015; 46: 738-749
Year: 2015
Aquoaporin-1 expression in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Biomarkers in pulmonary hypertension associated to interstitial lung disease
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Pattern of airway inflammation and remodeling in mild chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Pertechnegas lung clearance in different forms of interstitial lung disease
Source: Eur Respir J 2002; 19: 31-36
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept